English
Español
☰
About ObsITI
At a glance
Immune Tolerance Induction (ITI)
Patient inclusion and exclusion criteria
Current status
Success criteria
Satellite Studies
Product / batch selection for individualised ITI
Thrombin Generation Test (TGT) to monitor the haemostatic efficacy of FVIII
F8
gene analysis / Immunogenotyping / HLA genotyping
Thrombin generation assay (TGA)
Immune-monitoring of patients undergoing ITI
Epitope mapping / IgG isotyping
Inhibitor Binding Affnity (IBA)
Who we are
Principle investigator and Study co-ordinator
Co-investigators
Scientific ObsITI board / DMC
How to join the study
Current news
News
Publications
News
Upcoming Events
ObsITI Steering Committee Meeting. EAHAD 2019, Prague, Czech Republic
International open-label, uncontrolled, non-interventional, multi-centre observational program conducted by the HZRM, Frankfurt-Mörfelden, Germany